RecallReported October 14, 2026
Class II recall by K.C. Pharmaceuticals, Inc.
Sterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) bottles,…
FDA's enforcement report of October 14, 2026 lists a Class II recall by K.C. Pharmaceuticals, Inc. of Pomona, CA. Product: Sterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) bottles,…. Status: Ongoing.
On the record
- Recalling firm
- K.C. Pharmaceuticals, Inc.
- Location
- Pomona, CA
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0004-2027
- Product type
- Drugs
- Brand names
- LEADER ADVANCED RELIEF EYE DROPS, GOODSENSE EYE DROPS ADVANCED RELIEF MOISTURIZER, MEDICS CHOICE EYE DROPS ADVANCED, FOSTER AND THRIVE ADVANCED RELIEF EYE DROPS, QUALITY CHOICE MOISTURIZING RELIEF EYE DROPS
- Generic names
- DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL, DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL, TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, DEXTRAN 70, POVIDONE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL
- Recall initiated
- 2026-09-11
- Reported by FDA
- 2026-10-14
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch K.C. Pharmaceuticals, Inc
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with K.C. Pharmaceuticals, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.